Sugi Predict

Sugi Predict / Compounds / SCHEMBL2453090

SCHEMBL2453090

SCHEMBL2453090

CCOC(=O)n1nc2c(c1NC(=O)c1ccc(N(C)C)cc1[N+](=O)[O-])CN(C(=O)OC(C)(C)C)CC2(C)C

nearest known ligand 0.34

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.34
▸ LMNA P02545 3/20 0.34
▸ NR1H2 P55055 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ MCL1 Q07820 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ THRB P10828 1/20 0.31
▸ POLB P06746 1/20 0.30
▸ ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4278110 0.88 C5AR1 (0.35) MAPTLMNANPSR1SMN1; SMN2ALDH1A1
SCHEMBL1891834 0.88 ALDH1A1 (0.42) LMNANR1H2NPSR1SMN1; SMN2ALDH1A1
SCHEMBL1892811 0.86 L3MBTL1 (0.35) MAPTLMNANR1H2NPSR1ALDH1A1
SCHEMBL1887656 0.86 MAPT (0.39) MAPTLMNASMN1; SMN2ALDH1A1POLB
SCHEMBL1893808 0.86 MAPT (0.38) MAPTLMNANPSR1SMN1; SMN2ALDH1A1
SCHEMBL2677503 0.82 MAPT (0.36) MAPTLMNANPSR1SMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL2677500 0.81 MAPT (0.36) MAPTLMNANPSR1SMN1; SMN2ALDH1A1
SCHEMBL4286497 0.81 MAPT (0.38) MAPTLMNANPSR1SMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL4286492 0.81 MAPT (0.37) MAPTLMNANPSR1SMN1; SMN2ALDH1A1
SCHEMBL1890661 0.80 MAPT (0.35) MAPTLMNANPSR1ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173659-B2 Substituted pyrazolo[4,3-C]pyridine derivatives active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-05-08 — — US disclosed
US-20110230470-A1 SUBSTITUTED PYRAZOLO[4,3-C]PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2011-09-22 — — US disclosed
US-20090023745-A1 Substituted Pyrazolo[4,3-c]Pyridine Derivatives Active as Kinase Inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2009-01-22 — — US disclosed
EP-1968976-A1 SUBSTITUTED PYRAZOLO [4,3-C] PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.r.l. (IT) 2008-09-17 — — EP disclosed
WO-2007068619-A1 SUBSTITUTED PYRAZOLO [4,3-C] PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2007-06-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230470-A1 SUBSTITUTED PYRAZOLO[4,3-C]PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS MAP3K3, MAP3K1, MAP3K19 MAPT 2600/4885LMNA 3253/4885NR1H2 4008/4885
US-20090023745-A1 Substituted Pyrazolo[4,3-c]Pyridine Derivatives Active as Kinase Inhibitors MAP3K3, MAP3K1, MAP3K19 MAPT 2600/4885LMNA 3253/4885NR1H2 4008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.